These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26670202)

  • 1. Characterization of clear cell renal cell carcinoma by gene expression profiling.
    Thibodeau BJ; Fulton M; Fortier LE; Geddes TJ; Pruetz BL; Ahmed S; Banes-Berceli A; Zhang PL; Wilson GD; Hafron J
    Urol Oncol; 2016 Apr; 34(4):168.e1-9. PubMed ID: 26670202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma.
    Tan X; Zhai Y; Chang W; Hou J; He S; Lin L; Yu Y; Xu D; Xiao J; Ma L; Wang G; Cao T; Cao G
    Int J Cancer; 2008 Sep; 123(5):1080-8. PubMed ID: 18546293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F; Parker AS; Kube DM; Lohse CM; Leibovich BC; Blute ML; Cheville JC; Vasmatzis G
    Clin Cancer Res; 2005 Jul; 11(14):5128-39. PubMed ID: 16033827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
    BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of an eight-gene expression signature for predicting high Fuhrman grade renal cell carcinoma.
    Wan F; Zhu Y; Han C; Xu Q; Wu J; Dai B; Zhang H; Shi G; Gu W; Ye D
    Int J Cancer; 2017 Mar; 140(5):1199-1208. PubMed ID: 27874173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling microRNA from nephrectomy and biopsy specimens: predictors of progression and survival in clear cell renal cell carcinoma.
    Kowalik CG; Palmer DA; Sullivan TB; Teebagy PA; Dugan JM; Libertino JA; Burks EJ; Canes D; Rieger-Christ KM
    BJU Int; 2017 Sep; 120(3):428-440. PubMed ID: 28432832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized discovery of altered pathways in clear cell renal cell carcinoma using accumulated normal sample data.
    Wang X; Ding M; Yang Y; Feng Y; Shi Z; Qiu F; Zhu M
    J BUON; 2016; 21(2):390-8. PubMed ID: 27273949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P; Ye L; Yang Y; Jiang WG
    Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The expression of hypoxia inducible factor-1,2 alpha in sporadic clear cell renal cell carcinoma and their relationships to the mutations of von Hippel-Lindau gene].
    Gong K; Zhang N; Na X; Wu G; Yang XY; Xin DQ; Na YQ
    Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(6):390-3. PubMed ID: 15854350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.
    Wrzesiński T; Szelag M; Cieślikowski WA; Ida A; Giles R; Zodro E; Szumska J; Poźniak J; Kwias Z; Bluyssen HA; Wesoly J
    BMC Cancer; 2015 Jul; 15():518. PubMed ID: 26169495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma.
    Petrozza V; Carbone A; Bellissimo T; Porta N; Palleschi G; Pastore AL; Di Carlo A; Della Rocca C; Fazi F
    Int J Mol Sci; 2015 Dec; 16(12):29219-25. PubMed ID: 26670229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and confirmation of potential gene classifiers of human clear cell renal cell carcinoma using next-generation RNA sequencing.
    Eikrem OS; Strauss P; Beisland C; Scherer A; Landolt L; Flatberg A; Leh S; Beisvag V; Skogstrand T; Hjelle K; Shresta A; Marti HP
    Scand J Urol; 2016 Dec; 50(6):452-462. PubMed ID: 27739342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GFOD1 and peejar are promising markers for clear-cell renal cell carcinoma disease progression.
    Wu XR; Chen YH; Chen W; Kong W; Huang JW; Zhang J; Xue W; Liu DM; Huang YR
    Oncotarget; 2016 Jun; 7(25):38004-38009. PubMed ID: 27191742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratification of clear cell renal cell carcinoma (ccRCC) genomes by gene-directed copy number alteration (CNA) analysis.
    Thiesen HJ; Steinbeck F; Maruschke M; Koczan D; Ziems B; Hakenberg OW
    PLoS One; 2017; 12(5):e0176659. PubMed ID: 28486536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma.
    Schrödter S; Braun M; Syring I; Klümper N; Deng M; Schmidt D; Perner S; Müller SC; Ellinger J
    Mol Cancer; 2016 Feb; 15():10. PubMed ID: 26831905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hZIP1 that is down-regulated in clear cell renal cell carcinoma is negatively associated with the malignant potential of the tumor.
    Dong X; Kong C; Zhang Z; Liu X; Zhan B; Chen Z; Shi D
    Urol Oncol; 2014 Aug; 32(6):885-92. PubMed ID: 24878177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.